The following are publications relating to iron overload and iron chelation therapy.
2008 | Haematologica
Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. (Di Tucci A.A., Matta G., et al.)
2008 | Int J Hematol
MDS Foundation's Working Group on Transfusional Iron Overload. Consensus statement on iron overload in myelodysplastic syndromes. (Bennett J.M.)
2008 | Blood Rev
Cardiac iron across different transfusion-dependent diseases. (Wood, J.C. )
2008 | Haematologica
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. (Angelucci E., Barosi G., et al.)
2008 | Am J Hematol
MDS Foundation's Working Group on Transfusional Iron Overload. Consensus statement on iron overload in myelodysplastic syndromes. (Bennett J.M.)
2008 | Am J Hematol
Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. (Chee C.E., Steensma D.P., et al.)
2008 | J Cardiovasc Med (Hagerstown)
Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE). Guideline recommendations for heart complications in thalassemia major. (Cogliandro T., Derchi G., et al.)
2008 | Blood Rev
The role of iron in patients after bone marrow transplantation. (de Witte T.)
2008 | Transfusion
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. (Fung E.B., Harmatz P.R., et al. Multi-Center Iron Overload Research Group)
2008 | Int J Hematol
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. (Gattermann N.)
2008 |Am J Cardiol
Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia. (Isma'eel H., Chafic A.H., et al.)
2008 | Acta Haematol
Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. (Kim Y.R., Kim J.S., et al.)
2008 | Isr Med Assoc J
Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines. (Mittelman M, Lugassy G, et al. MDS Israel Group; Israel Society of Hematology)
2008 | J Cardiovasc Magn Reson
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. (Modell B., Khan M., et al.)
2008 | Bone Marrow Transplant
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. (Pullarkat V., Blanchard S., et al.))
2008 | Int J Hematol
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes. (Suzuki T., Tomonaga M., et.al.)
2008 | Thalassemia International Federation
Guidelines for the clinical management of thalassemia, 2nd Edition 2008.
2008 | The Sickle Cell Society
Standards for the clinical care of adults with sickle cell disease in the UK 2008.
2008 | Leuk Res
Iron overload in myelodysplastic syndromes: A Canadian consensus guideline.; (Wells R.A. et al.)
2008 | National Comprehensive Cancer Network
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology – v2: Myelodysplastic Syndromes
Email
Print